A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day acquisition of multi-drug resistant bacterial and fungal infections for 151 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.

<p>A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day acquisition of multi-drug resistant bacterial and fungal infections for 151 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.</p>